Prosthetic heart valve thrombosis

GD Dangas, JI Weitz, G Giustino, R Makkar… - Journal of the American …, 2016 - jacc.org
Although surgery was the mainstay of treatment for valvular heart disease, transcatheter
valve therapies have grown exponentially over the past decade. Two types of artificial heart …

Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week

M Alkhouli, PA Friedman - Journal of the American College of Cardiology, 2019 - jacc.org
The last decade has witnessed remarkable advances in pharmacological and
nonpharmacological strategies for stroke prevention in patients with atrial fibrillation …

Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation

L Melgaard, A Gorst-Rasmussen, DA Lane… - Jama, 2015 - jamanetwork.com
Importance The CHA 2 DS 2-VASc score (congestive heart failure, hypertension, age≥ 75
years [doubled], diabetes, stroke/transient ischemic attack/thromboembolism [doubled] …

Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation …

GYH Lip, C Laroche, PM Ioachim… - European heart …, 2014 - academic.oup.com
Abstract Background The EURObservational Research Programme-Atrial Fibrillation
General Registry Pilot Phase (EORP-AF Pilot) provides systematic collection of …

Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis

TJ Siddiqi, MS Usman, I Shahid… - European Journal of …, 2022 - academic.oup.com
Aims Anticoagulants are the mainstay treatment for stroke prevention in patients with non-
valvular atrial fibrillation (NVAF), and the CHA2DS2-VASc score is widely used to guide …

Usefulness of CHADS2 and CHA2DS2-VASc scores in the prediction of new-onset atrial fibrillation: a population-based study

W Saliba, N Gronich, O Barnett-Griness… - The American journal of …, 2016 - Elsevier
Abstract Background CHADS 2 and CHA 2 DS 2-VASc are validated scores used to predict
stroke in patients with atrial fibrillation. Many of the individual risk factors included in these …

Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study

M Anjum, I Ariansen, V Hjellvik, R Selmer… - European heart …, 2024 - academic.oup.com
Abstract Background and Aims The benefit of oral anticoagulant (OAC) therapy in atrial
fibrillation (AF) and intermediate stroke risk is debated. In a nationwide Norwegian cohort …

A clinical score for predicting atrial fibrillation in patients with cryptogenic stroke or transient ischemic attack

C Kwong, AY Ling, MH Crawford, SX Zhao, NH Shah - Cardiology, 2017 - karger.com
Objectives: Detection of atrial fibrillation (AF) in post-cryptogenic stroke (CS) or transient
ischemic attack (TIA) patients carries important therapeutic implications. Methods: To risk …

Refining Prediction of Atrial Fibrillation–Related Stroke Using the P2-CHA2DS2-VASc Score: ARIC and MESA

A Maheshwari, FL Norby, NS Roetker, EZ Soliman… - Circulation, 2019 - Am Heart Assoc
Background: In people with atrial fibrillation (AF), periods of sinus rhythm present an
opportunity to detect prothrombotic atrial remodeling through measurement of P-wave …

Clinical application of a novel genetic risk score for ischemic stroke in patients with cardiometabolic disease

NA Marston, PN Patel, FK Kamanu, F Nordio… - Circulation, 2021 - Am Heart Assoc
Background: Genome-wide association studies have identified single-nucleotide
polymorphisms that are associated with an increased risk of stroke. We sought to determine …